BioAge develops a pipeline of treatments to extend healthy lifespan by targeting the molecular causes of aging by using its discovery platform, which combines quantitative analysis of proprietary longitudinal human samples with detailed health records tracking individuals over the lifespan, to map out the key molecular pathways that impact healthy human aging.

Register for Details

For more details on financing and valuation for BioAge, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about BioAge

Forge green plus iconForge green minus icon

What is BioAge's IPO price?

The IPO price for BioAge will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in BioAge?

BioAge is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell BioAge shares pre-IPO?

If you own BioAge pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is BioAge a publicly traded company?

BioAge is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is BioAge's funding to date?

BioAge has raised $321.26MM to date.
Forge green plus iconForge green minus icon

When was BioAge founded?

BioAge was founded in 2015.

Who are BioAge's major investors?

Redpoint Ventures
Ra Capital Management
AME Cloud Ventures
Longitude Capital
Caffeinated Capital
Bossanova Investimentos
Felicis
Cormorant Asset Management
Pear VC
Green Sands Equity
Sofinnova Investments
RTW Investments
Sands Capital
Osage University Partners
OrbiMed
Summit Peak Investments
CSC UpShot Ventures
Pivotal bioVenture Partners
Summer VC
Amgen
AARP Foundation
Springboard Enterprises

BioAge Funding Rounds and Last Known Valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation
2/13/2024 Series D and D-1 $194.39MM raised $XXX.XX $XXX.XX
12/3/2020 Series C $90MM raised $XXX.XX $XXX.XX
1/24/2019 Series B $22.93MM raised $XXX.XX $XXX.XX
7/28/2017 Series A-1, A-2, A-3 and A-4 $13.93MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: May 21, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.